发明名称 |
Fusion enzymes |
摘要 |
The present disclosure relates to recombinant proteins having N-acetylglucosaminyltransferase activity. The present disclosure further relates to methods for producing complex N-glycans including the steps of providing host cells containing such recombinant proteins and culturing the host cells such that the recombinant proteins are expressed. |
申请公布号 |
US9399764(B2) |
申请公布日期 |
2016.07.26 |
申请号 |
US201113989084 |
申请日期 |
2011.11.24 |
申请人 |
Novartis International Pharmaceutical, Ltd.;Glykos Finland Oy |
发明人 |
Natunen Jari;Kanerva Anne;Hiltunen Jukka;Saloheimo Markku;Viskari Heli;Huuskonen Anne |
分类号 |
C12N9/10;C12P21/00;C12P19/18;C07K19/00;C12N15/80 |
主分类号 |
C12N9/10 |
代理机构 |
|
代理人 |
Halloran Patrick J. |
主权项 |
1. A method of producing a complex N-glycan, comprising:
(1) providing a filamentous fungal or yeast host cell,
wherein the host cell comprises a polynucleotide encoding a fusion protein comprising an N-acetylglucosaminyltransferase I catalytic domain and an N-acetylglucosaminyltransferase II catalytic domain,wherein the N-acetylglucosaminyltransferase II catalytic domain is positioned N-terminal to the N-acetylglucosaminyltransferase I catalytic domain, andwherein the alg3 gene is deleted from the host cell; and (2) culturing the filamentous fungal or yeast host cell such that the fusion protein is expressed, wherein the fusion protein catalyzes the transfer of N-acetylglucosamine to a terminal Manα3 residue and N-acetylglucosamine to a terminal Manα6 residue of an acceptor glycan to produce a complex N-glycan. |
地址 |
Hamilton BM |